Skip to main content
. 2025 Feb 4;14:34. doi: 10.1186/s13643-025-02772-9

Table 2.

Characteristics of included studies

Study, country, design Age (years) Sample size (n) Exercise intervention CARTS outcome
Exercise Control Exercise Control Frequency (days per week) Intensity Time, duration Type Supervision (yes/no)

Sacre et al., 2014 [35] (Australia)

Non-RCT

59 ± 10 60 ± 9 29 25 2 Moderate to vigorous (based on RPE and HR monitors) 20 to 40 min, for 12 weeks Aerobic + resistance Yes

-E:I ratio, Valsalva ratio, 30:15 ratio

-Cessation of anti-hypertensive medication (24 h), smoking, caffeine, alcohol (12 h), and heavy exercise (24 h)

-A quiet temperate room with 15-min supine

-As per standard protocol

Bonhof et al., 2022 [38]

(Germany)

Non- RCT

56 (53, 63)a 57 (53, 60)a 20 23 3 90% of HRmaxand 70% of HRmax 35 min, for 12 weeks HIIT Yes

-E:I ratio, Valsalva ratio, 30:15 ratio

-As per standard protocol

Bhati et al., 2023 [39] (India)

Parallel arm, single blinded RCT

52.8 ± 6.8 54.0 ± 8.18 28 28 3 Moderate. 65 to 75% of 1RM 60 min, for 12 weeks Progressive resistance Yes

-E:I ratio, Valsalva ratio, ∆HR deep breathing, ∆DBP, 30:15 ratio, ∆SBP (orthostatic test)

-ANS modifying medications ceased. 9 am to 12 pm

-As per standard protocol

CARTsCardiac autonomic reflex test, RCTRandomized controlled trial, RPERating of Perceived Exertion Scale, HRHeart rate, HRmaxMaximum heart rate, 1RM1 repetition maximum, HIITHigh-intensity interval training, E:IExpiration to inspiration ratio, DBPDiastolic blood pressure, SBPSystolic blood pressure

aMedian (interquartile range)